BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37972932)

  • 21. Diagnostic use of PAX8, CAIX, TTF-1, and TGB in metastatic renal cell carcinoma of the thyroid.
    Cimino-Mathews A; Sharma R; Netto GJ
    Am J Surg Pathol; 2011 May; 35(5):757-61. PubMed ID: 21451364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TROP-2, 5hmC, and IDH1 Expression in Anaplastic Thyroid Carcinoma.
    Seok JY; Astvatsaturyan K; Peralta-Venturina M; Lai J; Fan X
    Int J Surg Pathol; 2021 Jun; 29(4):368-377. PubMed ID: 33289434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms.
    Nonaka D; Tang Y; Chiriboga L; Rivera M; Ghossein R
    Mod Pathol; 2008 Feb; 21(2):192-200. PubMed ID: 18084247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
    Nozaki Y; Yamamoto H; Iwasaki T; Sato M; Jiromaru R; Hongo T; Yasumatsu R; Oda Y
    Hum Pathol; 2020 Dec; 106():82-92. PubMed ID: 32980422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors.
    Zhao LH; Chen C; Mao CY; Xiao H; Fu P; Xiao HL; Wang G
    Pathol Res Pract; 2019 Jul; 215(7):152448. PubMed ID: 31133441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.
    Nikitski AV; Rominski SL; Condello V; Kaya C; Wankhede M; Panebianco F; Yang H; Altschuler DL; Nikiforov YE
    Thyroid; 2019 Oct; 29(10):1425-1437. PubMed ID: 31298630
    [No Abstract]   [Full Text] [Related]  

  • 27. Primary Versus Secondary Anaplastic Thyroid Carcinoma: Perspectives from Multi-institutional and Population-Level Data.
    Ngo TNM; Le TTB; Le T; Bychkov A; Oishi N; Jung CK; Hassell L; Kakudo K; Vuong HG
    Endocr Pathol; 2021 Dec; 32(4):489-500. PubMed ID: 34559383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
    Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1
    Agaimy A; Fuchs F; Moskalev EA; Sirbu H; Hartmann A; Haller F
    Virchows Arch; 2017 Nov; 471(5):599-609. PubMed ID: 28555282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas.
    Rossi ED; Straccia P; Palumbo M; Stigliano E; Revelli L; Lombardi CP; Santeusanio G; Pontecorvi A; Fadda G
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):237-41. PubMed ID: 23235344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SMARCA4-deficient Thoracic Sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses.
    Perret R; Chalabreysse L; Watson S; Serre I; Garcia S; Forest F; Yvorel V; Pissaloux D; Thomas de Montpreville V; Masliah-Planchon J; Lantuejoul S; Brevet M; Blay JY; Coindre JM; Tirode F; Le Loarer F
    Am J Surg Pathol; 2019 Apr; 43(4):455-465. PubMed ID: 30451731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune Profiling of Advanced Thyroid Cancers Using Fluorescent Multiplex Immunohistochemistry.
    Ahn J; Jin M; Song E; Ryu YM; Song DE; Kim SY; Kim TY; Kim WB; Shong YK; Jeon MJ; Kim WG
    Thyroid; 2021 Jan; 31(1):61-67. PubMed ID: 32611231
    [No Abstract]   [Full Text] [Related]  

  • 33. Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours.
    Mohanty SK; Tiwari A; Bhardwaj N; Chuang F; Kim E; Lugo H; Yuan X; Diffalha SA; Peralta-Venturina M; Balzer B; Dhall D
    J Clin Pathol; 2021 Sep; 74(9):582-588. PubMed ID: 32934105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer.
    McFadden DG; Vernon A; Santiago PM; Martinez-McFaline R; Bhutkar A; Crowley DM; McMahon M; Sadow PM; Jacks T
    Proc Natl Acad Sci U S A; 2014 Apr; 111(16):E1600-9. PubMed ID: 24711431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laryngotracheal presentation of anaplastic thyroid carcinoma with squamous differentiation: seven cases demonstrating an under-recognized diagnostic pitfall.
    Toner M; Banville N; Timon CI
    Histopathology; 2014 Oct; 65(4):501-7. PubMed ID: 24593037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary cutaneous SMARCA4-deficient undifferentiated malignant neoplasm: A rare case report and literature review.
    Gumusgoz E; Graham BS; Hosler GA
    J Cutan Pathol; 2024 Apr; 51(4):262-266. PubMed ID: 38124373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A BAFfling liver aspirate: Metastatic high grade SMARCA4 deficient undifferentiated gastroesophageal junction carcinoma masquerading as a hematolymphoid malignancy.
    Kilic AI; Mirza K; Mehrotra S; Pambuccian SE
    Diagn Cytopathol; 2019 Jul; 47(7):725-732. PubMed ID: 30897306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of T-cell immunoreceptor with immunoglobulin and tyrosine-based inhibitory motif domains (TIGIT) in anaplastic thyroid carcinoma.
    Nakazawa T; Nagasaka T; Yoshida K; Hasegawa A; Guo F; Wu D; Hiroshima K; Katoh R
    BMC Endocr Disord; 2022 Aug; 22(1):204. PubMed ID: 35971106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary mediastinal seminomas: a comprehensive immunohistochemical study with a focus on novel markers.
    Weissferdt A; Rodriguez-Canales J; Liu H; Fujimoto J; Wistuba II; Moran CA
    Hum Pathol; 2015 Mar; 46(3):376-83. PubMed ID: 25576290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cauda Equina Neuroendocrine Tumors: Distinct Epithelial Neuroendocrine Neoplasms of Spinal Origin.
    Asa SL; Mete O; Schüller U; Ramani B; Mirchia K; Perry A
    Am J Surg Pathol; 2023 Apr; 47(4):469-475. PubMed ID: 36543154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.